Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination

Matteo Sacchi, Claudia Specchia, Susan E. Williams, Edoardo Villani, Paolo Nucci

Research output: Contribution to journalArticle

Abstract

Purpose: To evaluate the efficacy and safety of bimatoprost plus timolol fixed combination (BTFC) in patients with primary open angle glaucoma (POAG) previously treated with dorzolamide plus timolol fixed combination (DTFC).Materials and methods: Retrospective, medical records review study. Medical records of patients with POAG previously treated with DTFC and then switched to BTFC for poor intraocular pressure (IOP) control or ocular discomfort were included in the analysis. One baseline IOP diurnal curve, and one diurnal curve under each treatment were required to be eligible for this study. The primary outcome was to compare the mean diurnal IOP between DTFC and BTFC. Secondary outcomes were to compare the IOP diurnal fluctuation, and the percentage of patients achieving a target IOP

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalCurrent Eye Research
DOIs
Publication statusAccepted/In press - Apr 8 2016

Keywords

  • Bimatoprost plus timolol fixed combination
  • dorzolamide plus timolol fixed combination
  • intraocular pressure
  • intraocular pressure fluctuations
  • open angle glaucoma

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination'. Together they form a unique fingerprint.

  • Cite this